Elimidrol

$1.4 million judgment (partially suspended) / Prohibited from making claims about substance or opioid use and withdrawal claim or any disease claim unless substantiated by competent and reliable scientific evidence that is sufficient in quality and quantity, based on standards generally accepted by experts in the relevant disease, condition, or function to which the representation relates, when considered in light of the entire body of relevant and reliable evidence / Such testing shall be randomized, double-blind, and placebo-controlled and conducted by qualified persons / Other health-related claims must be supported by competent and reliable scientific evidence conducted and evaluated by experts in the relevant disease, condition, or function to which the representation relates, and must be randomized, double-blind, and placebo-controlled when required such experts.